Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheney J G Drew

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMJ Open|August 1, 2024
Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's diseaseVasileios Ioakeimidis, Monica Busse, Cheney J G Drew, et al.
Pilot and Feasibility Studies|July 20, 2019
A protocol for a randomised controlled, double-blind feasibility trial investigating fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, Learning and Memory in Epilepsy (FLAME trial)Cheney J G Drew, Mark Postans, Cateno Petralia, et al.
Pilot and Feasibility Studies|February 16, 2018
Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility studyEmma Yhnell, Hannah Furby, Rachel S Breen, et al.
Pilot and Feasibility Studies|June 25, 2020
A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD)Emma Yhnell, Hannah Furby, Rachel S Lowe, et al.
Brain : a Journal of Neurology|September 14, 2013
Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delayRhys H Thomas, Seo-Kyung Chung, Sian E Wood, et al.
Physical Therapy|May 19, 2019
Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington DiseaseCheney J G Drew, Lori Quinn, Katy Hamana, et al.
Parkinsonism & Related Disorders|July 9, 2022
Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseLori Quinn, Rebecca Playle, Cheney J G Drew, et al.
Brain Communications|February 5, 2021
Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington's diseaseCheney J G Drew, Feras Sharouf, Elizabeth Randell, et al.
Human Molecular Genetics|November 28, 2012
GLRB is the third major gene of effect in hyperekplexiaSeo-Kyung Chung, Anna Bode, Thomas D Cushion, et al.
The Journal of Biological Chemistry|June 16, 2012
Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle diseaseEloisa Carta, Seo-Kyung Chung, Victoria M James, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMJ Open|August 1, 2024
Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's diseaseVasileios Ioakeimidis, Monica Busse, Cheney J G Drew, et al.
Pilot and Feasibility Studies|July 20, 2019
A protocol for a randomised controlled, double-blind feasibility trial investigating fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, Learning and Memory in Epilepsy (FLAME trial)Cheney J G Drew, Mark Postans, Cateno Petralia, et al.
Pilot and Feasibility Studies|February 16, 2018
Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility studyEmma Yhnell, Hannah Furby, Rachel S Breen, et al.
Pilot and Feasibility Studies|June 25, 2020
A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD)Emma Yhnell, Hannah Furby, Rachel S Lowe, et al.
Brain : a Journal of Neurology|September 14, 2013
Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delayRhys H Thomas, Seo-Kyung Chung, Sian E Wood, et al.
Physical Therapy|May 19, 2019
Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington DiseaseCheney J G Drew, Lori Quinn, Katy Hamana, et al.
Parkinsonism & Related Disorders|July 9, 2022
Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseLori Quinn, Rebecca Playle, Cheney J G Drew, et al.
Brain Communications|February 5, 2021
Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington's diseaseCheney J G Drew, Feras Sharouf, Elizabeth Randell, et al.
Human Molecular Genetics|November 28, 2012
GLRB is the third major gene of effect in hyperekplexiaSeo-Kyung Chung, Anna Bode, Thomas D Cushion, et al.
The Journal of Biological Chemistry|June 16, 2012
Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle diseaseEloisa Carta, Seo-Kyung Chung, Victoria M James, et al.
Pageof 3